By 2034, the transformation of in-vitro inflammatory bowel disease (IBD) diagnostics through artificial intelligence (AI) is expected to be substantial and profound. The growing prevalence of IBD, including Crohn's disease and ulcerative colitis, combined with the pressing need for personalized
In a groundbreaking advancement, researchers have introduced a less invasive, cost-effective solution for diagnosing Alzheimer's disease, promising to transform how the condition is detected and treated. Historically, diagnosing Alzheimer's has been a challenging and intricate process, heavily
In an era where medical diagnostics are rapidly evolving, artience Co., Ltd., based in Tokyo, is poised to make a significant impact with its new Sciforiem™ PL 1000 Series of synthetic polymers. Initially launched in Japan, these innovative materials are now being made available globally, marking a
The swift development and deployment of COVID-19 rapid antigen tests during the height of the pandemic represented a significant stride in public health response. Facilitated by the U.S. Food and Drug Administration's Emergency Use Authorization, these tests promised quick results, enabling timely
Over the past several years, Kenya's in vitro diagnostics (IVD) market has demonstrated impressive advancements, fueled by a confluence of technological innovations and an increasing need to address infectious and chronic diseases. The high prevalence of diseases like HIV, tuberculosis (TB), and
The In Vitro Diagnostics (IVD) market in India is positioned for remarkable growth, projected to expand from USD 2.64 billion in 2024 to an impressive USD 4.77 billion by 2034. This anticipated development reflects a robust compound annual growth rate (CAGR) of 6.10%. As advancements in molecular
